Kangmei Pharma | 600518 - Operating Expenses

Stock Price
1.88
Daily Change
0.01 0.53%
Monthly
-1.57%
Yearly
-14.93%
Q1 Forecast
1.84

Kangmei Pharma reported CNY1.39B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Genomma Lab Internacional MXN 3.22B 257.3M Dec/2025
Hypermarcas BRL 1.55B 45.76M Sep/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Jiangsu Hengrui CNY 5.94B 254.97M Sep/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Sh Fosun Pharma CNY 9.12B 194.06M Sep/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Viatris USD 3.86B 335.7M Dec/2025
Wuxi Apptec CNY 7.48B 202.41M Sep/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025